Concord Medical Regains Compliance with NYSE Minimum Price Requirement

Group 1 - Concord Medical Services Holdings Limited has regained compliance with the NYSE's minimum average share price requirement of US$1.00 over a 30 trading-day period, as notified by the NYSE on August 6, 2024 [1] - The company had previously received a compliance notice from the NYSE on February 12, 2024, indicating it was below the compliance standards due to the trading price of its American Depositary Shares [1] Group 2 - Concord Medical is a healthcare provider specializing in a full cycle of premium oncology services, including cancer diagnosis, treatment, education, and prevention [2] - The company aims to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics, as well as partnered hospitals across China [2] - Concord Healthcare, a subsidiary of Concord Medical, provides oncology healthcare services through both self-owned and third-party medical institutions, focusing on precision radiation therapy and integrated oncology-related services [3]